google-site-verification: googlec7193c3de77668c9.html

Tirzepatide noninferior to dulaglutide for CV outcomes in type 2 diabetes

[
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according to a study published in the Dec. 18/25 issue of the New England Journal of Medicine.


Source link

Advertisements
Views: 0

See also  Shoplifter's getaway foiled by chief constable

Check Also

Prior heart attack linked to faster declines in thinking and memory skills

[ Credit: Pixabay/CC0 Public Domain The chance of developing cognitive impairment was significantly higher for …

The goal of a Tobacco-Free Generation will not progress without stronger EU support, experts suggest

[ Credit: Unsplash/CC0 Public Domain A recent study shows that the rapid increase of new …

New review confirms alcohol causes dozens of health harms, some reversible

[ A new review published in the journal Addiction confirms drinking causes substantial harm to …

Leave a Reply

Available for Amazon Prime
Link. Sonuç : cassinox bahis dünyasında neden fark yaratacak ?.